Structure, Biology, and Therapeutic Implications of Pegylated Interferon Alpha-2b

E-ISSN： 1873-4286|8|24|2139-2157

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.24, 2002-11, pp. : 2139-2157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis C: A Randomized Open-Label Study of Pegylated Interferon-α-2a versus Pegylated Interferon-α-2b

By Scotto Gaetano

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 791-801

Adis International

Access to resources Recommend Favorite

Bilateral Skin Ulceration after Injection of Pegylated Interferon- -2b in a Patient with Chronic Hepatitis C

By Gallelli L.

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 615-619

Adis International

Access to resources Recommend Favorite

Generalised Dermatitis Induced by Pegylated Interferon- -2b in a Patient Infected with Genotype-1 Hepatitis C Virus: Presentation of a Case

By Gallelli L.

Clinical Drug Investigation, Vol. 25, Iss. 4, 2005-01 ,pp. : 281-284

Adis International

Access to resources Recommend Favorite

Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C

By Jansen Peter LM De Bruijne Joep

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 111-118

Informa Healthcare

Access to resources Recommend Favorite

2 -Adrenergic Receptors: Structure, Function and Therapeutic Implications

By Insel P.A.

Trends in Pharmacological Sciences, Vol. 19, Iss. 3, 1998-03 ,pp. : 116-116

Elsevier

Access to resources Recommend Favorite